MOLINA HEALTHCARE, INC. (MOH) stock intrinsic value fair value estimate & owner earnings analysis

Molina Healthcare administers Medicaid, Medicare and ACA Marketplace health plans on behalf of state and federal governments, currently across 21 states. It collects a fixed premium per enrolled member and keeps the difference between that premium and what it pays out in medical claims, subject to periodic rate-setting and actuarial review by its government counterparties. State Medicaid contracts typically run three to five years with renewal options, giving the business real recurring-revenue characteristics, and Molina has a long history of winning and keeping this business. To estimate the cash a shareholder could actually pocket each year, we started from operating cash flow, added back non-cash items such as depreciation and one-time impairment or restructuring charges (real historical costs, but not costs of running today's business), counted stock-based compensation as a genuine expense, and set aside the swings in medical-claims reserves and government receivables/payables that are timing effects rather than economics. On that basis, per-share owner earnings ran about $12 in 2019-2020, rose to a peak of roughly $23 in 2024, and then fell back to about $12 in 2025. That drop tracks a shift Molina describes in its own filings: the unwinding of pandemic-era Medicaid eligibility rules ("redetermination") has left a smaller but sicker Medicaid membership, and the cost of caring for that population ran ahead of the premium rates states approved to pay for it (the company's medical care ratio rose from 89.1% in 2024 to 91.7% in 2025). Management calls this gap temporary, but results through the first half of 2026 still show it had not closed - reported net income for that half was well below the same period a year earlier. A portion of the 2025 shortfall also reflects a one-time retroactive premium adjustment in California recognized in the fourth quarter. Working in the company's favor are two things already in hand. First, in late 2025 Molina was awarded or renewed a group of state Medicaid contracts, most notably a new sole-source Florida Medicaid and children's health contract estimated at $6 billion of annual premium revenue starting in the fourth quarter of 2026, alongside a Wisconsin renewal and new business in Georgia and Texas - together over $9 billion of additional annual premium revenue once phased in. Second, Molina's decades-long record of winning and retaining state Medicaid business is itself a durable asset: states rarely switch administrators once established, and the bidding and compliance requirements are a real barrier to entry. Working against the company are two further headwinds named in its own filings: a 2025 federal law is expected to remove 15-20% of the roughly 1.2 million members in Molina's Medicaid expansion population over the next two to three years, with a further shift toward costlier remaining members; and the expiration of enhanced ACA Marketplace subsidies in 2025 is expected to shrink Marketplace membership and worsen the health mix of who remains. Separately, Molina has been taking on more debt - long-term borrowings rose about 29% during 2025 - partly to keep funding a large share-buyback program even as earnings fell, leaving less room for error if the current pressure runs longer than expected. Three cases: Bear ($154/share): the rate-and-cost gap does not close on management's expected timeline, the federal membership cuts land at the high end of the guided range, and the new contracts ramp slowly, as new Medicaid business typically does in its first year or two. Per-share owner earnings stay depressed through the late 2020s, recovering only partway to a plateau around $9.50-12.50, which we treat as sustaining indefinitely given Molina's demonstrated ability to keep renewing this kind of business, without assuming any further improvement. Base ($309/share): the imbalance narrows over roughly two annual state rate-setting cycles - about the timeline it took Molina to work through a similar pricing problem in 2017-2018 - while the newly awarded contracts, led by Florida, come online through 2026-2029 and reach normal profitability once past their initial ramp period. Owner earnings, still weak in 2026, recover to roughly $20-21 per share by the mid-2030s and are treated as sustaining at that level indefinitely, reflecting Molina's long record of renewing and adding state contracts rather than further margin expansion beyond that point. Bull ($431/share): the same recovery happens faster and more completely - rate catch-up largely finishes within about a year, the federal membership impact lands at the low end of the guided range, and all four newly won contracts reach target profitability ahead of schedule, consistent with Molina's track record integrating large new state contracts. Owner earnings reach roughly $30 per share by the mid-2030s and are sustained at that level. In every case we treated 2026 as another weak year - the first half of 2026 showed earnings still well below the prior year - rather than assuming an immediate turnaround, and we have not assumed any recovery beyond what the specific, already-visible drivers above can support. One thing we could not fully reconcile: cash generated by the business swung from a $112 million outflow in the first half of 2025 to a $788 million inflow in the first half of 2026, even as reported net income fell sharply over the same stretch. We believe this reflects working-capital timing (such as the pace of paying down claims reserves or receiving government settlements) rather than a change in the underlying earnings trend, but the filings did not provide enough detail to confirm this, so we relied on the more conservative earnings trend rather than the improving cash trend. The margin-of-safety price is $140 per share. Given that the underlying pressure was still building as of the most recent reported quarter, it applies once at least one quarter shows the cost-to-premium gap actually narrowing, rather than assuming the worst is already behind the company.